Category: Company News
-

Victory Marine Holdings Reduces Convertible Debt by More Than 95% as Commercial Expansion Accelerates (USOTC:VMHG)
Victory Marine Holdings reported a significant reduction in convertible debt alongside continued commercialization of its beverage and wellness platform, marking the first full quarter of execution following its March 2026 reverse merger. Key Investor Takeaways Why VMHG Stock Is in Focus Victory Marine Holdings (USOTC:VMHG), through its operating subsidiary Dunn & Groux Beverage Holdings, highlighted…
-

Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
Cardiff Oncology has secured a $10 million registered direct offering, providing additional capital for working capital and general corporate purposes as the company continues advancing its lead oncology program. Key Investor Takeaways Why CRDF Stock Is in Focus Cardiff Oncology (NASDAQ:CRDF) announced definitive agreements for a registered direct offering expected to generate approximately $10 million…
-

Rekor Systems Reports Preliminary Q2 Financial Improvement as Cost Cuts Drive Toward Adjusted EBITDA Profitability
Rekor Systems’ preliminary second-quarter results point to stronger operating performance following a broad restructuring effort, while management now expects to reach Adjusted EBITDA profitability during the second half of 2026. Key Investor Takeaways Why REKR Stock Is in Focus Rekor Systems (NASDAQ:REKR) reported preliminary, unaudited second-quarter 2026 financial results that suggest meaningful progress in its…
-

VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth
The milestone payment strengthens VivoSim’s cash position while management projects significant revenue growth driven by expanding demand for its human-based preclinical testing platform. Key Investor Takeaways Why VIVS Stock Is In Focus The key catalyst is VivoSim’s announcement that it has received a $5 million milestone payment from Eli Lilly related to an inflammatory bowel…
-

VSee Health Outlines AI-Enabled Enterprise Infrastructure Strategy for Hospital Operations
VSee Health (NASDAQ:VSEE) highlighted its strategy to position its enterprise telehealth platform as the infrastructure layer for artificial intelligence adoption across hospitals, while pointing to continued growth in its healthcare network and enterprise business. Key Investor Takeaways Why VSEE Stock Is in Focus VSee Health outlined its long-term strategy for integrating artificial intelligence into its…
-

Ameerex Provides Update on North American Resource Program and Patagonia Lithium Joint Venture
Ameerex Corporation (USOTC:HIRU) outlined progress across its North American resource program and Patagonia Lithium joint venture while also providing updates on its ongoing audit, legal proceedings, and a potential share buyback initiative. Key Investor Takeaways Why HIRU Stock Is in Focus Ameerex provided an operational update covering multiple strategic initiatives across its resource portfolio. The…
-

Ensysce Biosciences Receives Final $5.3 Million NIDA Funding Installment for PF614-MPAR Development
Ensysce Biosciences (NASDAQ:ENSC) has received a $5.3 million award from the National Institute on Drug Abuse (NIDA), completing a multi-year federal grant totaling $15.1 million to support development of its Breakthrough Therapy-designated opioid candidate PF614-MPAR. Key Investor Takeaways Why ENSC Stock Is in Focus Ensysce announced it has received a Notice of Award for $5.3…
-

Haoxi Health Technology Signs Strategic Cooperation to Develop AI Digital Marketing System
Haoxi Health Technology (NASDAQ:HAO) has signed a strategic cooperation framework agreement with NOVA MEDIA to develop an AI digital marketing system aimed at automating content creation and enhancing digital marketing capabilities for healthcare advertisers. Key Investor Takeaways Why HAO Stock Is in Focus Haoxi Health Technology announced a strategic cooperation framework agreement with NOVA MEDIA…
-

Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform
Silo Pharma (NASDAQ:SMPL) announced that its wholly owned subsidiary, QwikAgents, has joined AMD’s AI Developer Program, giving the company access to AI development resources intended to support the expansion of its enterprise and consumer AI agent platform. Key Investor Takeaways Why SMPL Stock Is in Focus Silo Pharma announced that its QwikAgents subsidiary has joined…
-

GMEX Robotics Signs Letter of Intent for AI Platform Acquisition Focused on Social Intelligence
GMEX Robotics (NASDAQ:GMEX) has signed a non-binding letter of intent to acquire an artificial intelligence platform focused on social intelligence and human behavioral modeling, a move aimed at strengthening its AI capabilities for robotics deployed in real-world human environments. Key Investor Takeaways Why GMEX Stock Is in Focus GMEX Robotics announced plans to acquire an…